Research ArticleOriginal Article
Open Access

Modelling risk assessment for cervical cancer in symptomatic Saudi women

Wedad Al-Madani, Anwar E. Ahmed, Haitham Arabi, Sumaiah Al Khodairy, Nashmia Al Mutairi and Abdul Rahman Jazieh
Saudi Medical Journal May 2019, 40 (5) 447-451; DOI: https://doi.org/10.15537/smj.2019.5.24085

References

  1. ↵
    1. Arbyn M,
    2. Castellsagué X,
    3. de Sanjosé S,
    4. Bruni L,
    5. Saraiya M,
    6. Bray F,
    7. et al.
    (2011) Worldwide burden of cervical cancer in 2008. Ann Oncol 22:2675–2686.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Jemal A,
    2. Center MM,
    3. DeSantis C,
    4. Ward EM
    (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19:1893–1907.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Alhamlan FS,
    2. Al-Qahtani AA,
    3. Al-Ahdal MN
    (2015) Current studies on human papillomavirus in Saudi Arabia. J Infect Deve Ctries 9:571–576.
    OpenUrl
  4. ↵
    1. Munoz N,
    2. Bosch FX,
    3. De Sanjosé S,
    4. Herrero R,
    5. Castellsagué X,
    6. Shah KV,
    7. et al.
    (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Al-Darwish AA,
    2. Al-Naim AF,
    3. Al-Mulhim KS,
    4. Al-Otaibi NK,
    5. Moris MS,
    6. Aleem AM
    (2014) Knowledge about cervical cancer early warning signs and symptoms, risk factors and vaccination among students at a medical school in Al-Ahsa, Kingdom of Saudi Arabia. Asian Pac Jof Cancer Prev 15:2529–2532.
    OpenUrl
  6. ↵
    1. Szostek S,
    2. Klimek M,
    3. Zawilinska B,
    4. Kosz-Vnenchak M
    (2008) Genotype-specific human papillomavirus detection in cervical smears. Acta Biochim Pol 55:687–692.
    OpenUrlPubMed
  7. ↵
    1. Walboomers JM,
    2. Jacob MV,
    3. Manos MM,
    4. Bosch FX,
    5. Kummar JA,
    6. Shah KV,
    7. et al.
    (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Sehgal A,
    2. Singh V
    (2009) Human papillomavirus infection (HPV) &screening strategies for cervical cancer. Indian J Med Res 130:234–240.
    OpenUrlPubMed
  9. ↵
    1. Moyer VA,
    2. U.S. Preventive Task Force
    (2012) Screening for cervical cancer:US Preventive Services Task Force recommendation statement. Ann Intern Med 156:880–891.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Chen C,
    2. Yang Z,
    3. Li Z,
    4. Li L
    (2012) Accuracy of several cervical screening strategies for early detection of cervical cancer:a meta-analysis. Int J Gynecol Cancer 22:908–921.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. National Institutes of Health
    (1996) Cervical cancer:NIH consensus statement (National Institutes of Health, Bethesda), pp 1–38.
  12. ↵
    1. Ferri FF
    Ferri's Netter Patient Advisor, Available from: https://www.elsevier.com/books/ferris-netter-patient-advisor/ferri/978-0-323-39324-9. [Updated 2016 January 28th].
  13. ↵
    1. Zhao L,
    2. Wentzensen N,
    3. Zhang RR,
    4. Dunn ST,
    5. Gold MA,
    6. Wang SS,
    7. et al.
    (2014) Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer. Cancer Cytopathol 122:694–701.
    OpenUrl
  14. ↵
    1. Nasser H,
    2. AlAyyaf M,
    3. Atallah A,
    4. Aminulislam M,
    5. Rizwan L,
    6. Aodah A,
    7. et al.
    (2017) Eleven-year review of data on pap smears in Saudi Arabia:we need more focus on glandular abnormalities! Ann Saudi Med 37:265–271.
    OpenUrl
  15. ↵
    1. Cardenas-Turanzas M,
    2. Follen M,
    3. Nogueras-Gonzalez GM,
    4. Benedet JL,
    5. Beck JR,
    6. Cantor SB
    (2008) The accuracy of the Papanicolaou smear in the screening and diagnostic settings. Journal of Lower Genital Tract Disease 12:269–275.
    OpenUrl
  16. ↵
    1. Harrell FE,
    2. Lee KL,
    3. Mark DB
    (1996) Multivariable prognostic models:issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. DeLong ER,
    2. DeLong DM,
    3. Clarke-Pearson DL
    (1988) Comparing the areas under two or more correlated receiver operating characteristic curves:a nonparametric approach. Biometrics 44:837–845.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Youden WJ
    (1950) Index for rating diagnostic tests. Cancer 3:32–35.
    OpenUrlCrossRefPubMedWeb of Science
    1. Ahmed AE,
    2. Alzahrani FS,
    3. Gharawi AM,
    4. Alammary SA,
    5. Almijmaj FH,
    6. Alhusayni FM,
    7. et al.
    (2018) Improving risk prediction for pancreatic cancer in symptomatic patients:a Saudi Arabian study. Cancer Manag Res 10:4981–4986.
    OpenUrl
  20. ↵
    1. Ahmed AE,
    2. McClish DK,
    3. Alghamdi T,
    4. Alshehri A,
    5. Aljahdali Y,
    6. Aburayah K,
    7. et al.
    (2019) Modeling risk assessment for breast cancer in symptomatic women:a Saudi Arabian study. Cancer Manag Res 11:1125–1132.
    OpenUrl
  21. ↵
    (2016) Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization (IHME, University of Washington, Seattle. (WA)).
  22. ↵
    1. Lacey JV Jr.,
    2. Swanson CA,
    3. Brinton LA,
    4. Altekruse SF,
    5. Barnes WA,
    6. Gravitt PE,
    7. et al.
    (2003) Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 98:814–821.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Nappi L,
    2. Indraccolo U,
    3. Sardo AD,
    4. Gentile G,
    5. Palombino K,
    6. Castaldi MA,
    7. et al.
    (2009) Are diabetes, hypertension, and obesity independent risk factors for endometrial polyps? J Minim Invasive Gynecol 16:157–162.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Oberaigner W,
    2. Ebenbichler C,
    3. Oberaigner K,
    4. Juchum M,
    5. Schönherr HR,
    6. Lechleitner M
    (2014) Increased cancer incidence risk in type 2 diabetes mellitus:results from a cohort study in Tyrol/Austria. BMC Public Health 14:1058.
    OpenUrl
  25. ↵
    1. DiSaia PJ,
    2. Chaudhuri G,
    3. Giudice LC,
    4. Moore TR,
    5. Smith LH,
    6. Porto MM
    (2012) Women's health review:a clinical update in obstetrics-gynecology (Saunders/Elsevier, Philadelphia), 1st ed.
  26. ↵
    1. Almughais ES,
    2. Alfarhan A,
    3. Salam M
    (2018) Awareness of primary health care physicians about human papilloma virus infection and its vaccination:a cross-sectional survey from multiple clinics in Saudi Arabia. Infect Drug Resist 11:2257–2267.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section